We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Five-year cost-effectiveness of the Patient Empowerment Programme ( PEP) for type 2 diabetes mellitus in primary care.
- Authors
Lian, Jinxiao; McGhee, Sarah M.; So, Ching; Chau, June; Wong, Carlos K. H.; Wong, William C. W.; Lam, Cindy L. K.
- Abstract
This study evaluated the short-term cost-effectiveness of the Patient Empowerment Programme ( PEP) for diabetes mellitus (DM) in Hong Kong. Propensity score matching was used to select a matched group of PEP and non- PEP subjects. A societal perspective was adopted to estimate the cost of PEP. Outcome measures were the cumulative incidence of all-cause mortality and diabetic complication over a 5-year follow-up period and the number needed to treat ( NNT) to avoid 1 event. The incremental cost-effectiveness ratio ( ICER) of cost per event avoided was calculated using the PEP cost per subject multiplied by the NNT. The PEP cost per subject from the societal perspective was US$247. There was a significantly lower cumulative incidence of all-cause mortality (2.9% vs 4.6%, P < .001), any DM complication (9.5% vs 10.8%, P = .001) and CVD events (6.8% vs 7.6%, P = .018), in the PEP group. The costs per death from any cause, DM complication or case of CVD avoided were US$14 465, US$19 617 and US$30 796, respectively. The extra amount allocated to managing PEP was small and it appears cost-effective in the short-term as an addition to RAMP.
- Subjects
HONG Kong (China); TYPE 2 diabetes treatment; PEOPLE with diabetes; COST effectiveness; MEDICAL care costs
- Publication
Diabetes, Obesity & Metabolism, 2017, Vol 19, Issue 9, p1312
- ISSN
1462-8902
- Publication type
Article
- DOI
10.1111/dom.12919